newsfilter
← Latest News
PR Newswire·

Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2025. Cash and investments in...